These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3455679

  • 1. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D, Tarella C, Pregno P, Pileri A, Gallo E.
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [Abstract] [Full Text] [Related]

  • 2. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1989 Feb; 37(1-2):17-28. PubMed ID: 2619501
    [Abstract] [Full Text] [Related]

  • 3. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Feb; 36(4):471-85. PubMed ID: 3074744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T, Hast R, Goldman JM.
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [Abstract] [Full Text] [Related]

  • 13. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 14. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL.
    Wien Med Wochenschr Suppl; 1986 Nov 12; 100():1-24. PubMed ID: 3471009
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J, Kvasnicka HM, Vardiman J.
    Best Pract Res Clin Haematol; 2006 Nov 12; 19(3):413-37. PubMed ID: 16781481
    [Abstract] [Full Text] [Related]

  • 18. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T.
    Acta Haematol Pol; 1992 Nov 12; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [Abstract] [Full Text] [Related]

  • 19. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders.
    Taetle R, Guittard JP, Mendelsohn JM.
    Exp Hematol; 1980 Nov 12; 8(10):1190-1201. PubMed ID: 6971757
    [Abstract] [Full Text] [Related]

  • 20. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V, Ohler L, Berer A, Kabrna E, Ofner P, Lechner K, Geissler K.
    Ann Hematol; 2004 Jan 12; 83(1):9-13. PubMed ID: 13680175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.